10 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... dosing and bridging ... #Oral #Anticoagulant ... #Anticoagulation ... #Loading #DVT #Pharmacology
Oral Anticoagulation - VTE and DVT Bridging

- Amelia Furbish PharmD Student @ https://www.instagram.com/happypillsrx/

#DOAC #Oral #Anticoagulant #VTE
Oral Anticoagulation ... happypillsrx/ #DOAC #Oral ... DVT #Bridging #Dosing ... #Pharmacology
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... conversions. ... the equinalgesic oral ... #Pharmacology #Pain ... Opiate #Opioid #Conversion
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... #DOAC #Dosing #Oral ... #Anticoagulation ... Comparison #Table #Pharmacology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... steroids, on ASA/anticoagulation ... Equianalgesia Conversion ... #Pain #Opioid #Conversion
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Rivaroxaban Oral ... Fibrillation requiring anticoagulation ... overview of the dosing ... #Rivaroxaban #Dosing ... #Pharmacology
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... P2Y12 Inhibitors Oral ... P2Y12 inhibitors during ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
patients on chronic anticoagulation ... direct acting oral ... clearance (calculated using ... may not require anticoagulation ... Management #Treatment #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching Between Oral ... the timing and dosing ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... -1 Agonist Dosing ... route by using ... been shown non-inferior ... semaglutide #Diabetes #Pharmacology